Regulatory News
Thursday, September 22, 2016
UPDATE 1-UK okays Alexion drug costing up to $2 mln but wants price cut
LONDON, Sept 22 (Reuters) - A new drug to treat a rare
inherited bone disorder that was developed by Alexion
Pharmaceuticals and could cost up to 1.5 million pounds
($2 million) a year per patient...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment